Trial intelligence / Profile preview

Preotact (1-84 parathyroid hormone) for proximal humerus fracture healing

2011-005801-54Phase 4Terminated

Sponsor
Copenhagen University Hospital - Hvidovre
Start
Feb 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of parathyroid hormone 1-84 in proximal humerus fracture (PHF), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: Constant shoulder score. Started Feb 2012; status: terminated.

02

Drugs

parathyroid hormone 1-84
03

Conditions

proximal humerus fracture (PHF)

Beyond the preview

Go deeper on 2011-005801-54.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-005801-54.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call